Company Filing History:
8 out of 8 
2 out of 2 
1 out of 208 
Years Active: 2003-2007
Title: Yumin Mao: Innovator in Biotechnology
Introduction
Yumin Mao is a prominent inventor based in Shanghai, China. He has made significant contributions to the field of biotechnology, particularly in the development of novel polypeptides and their applications in treating various diseases. With a total of 12 patents to his name, Mao's work is at the forefront of medical innovation.
Latest Patents
Mao's latest patents include groundbreaking inventions such as the polypeptide-human actin-binding protein 54 and a polynucleotide encoding the same. This invention discloses a novel polypeptide that plays a crucial role in the treatment of diseases like malignant tumors, blood diseases, HIV infections, immunological diseases, and various inflammations. Additionally, it introduces an antagonist against the polypeptide and outlines therapeutic uses for it. Another significant patent is the polypeptide-phosphatidic acid phosphatase 29.81, along with its encoding polynucleotide. This invention also details methods for producing the polypeptide through DNA recombinant technology and its application in treating conditions such as peripheral nervous demyelination, night blindness, rachitis, fatty liver, bronchial asthma, and peptic ulcers.
Career Highlights
Throughout his career, Yumin Mao has worked with notable companies in the biotechnology sector, including Shanghai Bio Road Gene Development and Shanghai Bio Window Gene Development. His expertise and innovative approach have positioned him as a key player in the industry.
Collaborations
Mao has collaborated with several professionals in his field, including Yi Xie and Xiaoyu Sheng. These partnerships have further enhanced his research and development efforts, leading to impactful advancements in biotechnology.
Conclusion
Yumin Mao's contributions to biotechnology through his innovative patents and collaborations highlight his role as a leading inventor in the field. His work continues to pave the way for new treatments and therapies that can significantly improve patient outcomes.